Datavant

About Datavant

Datavant is a health data technology company that specializes in enabling the secure exchange of patient information while preserving privacy. The company operates in the healthcare sector, focusing on the critical need for data sharing among healthcare providers, researchers, and other stakeholders. Datavant's primary product is software that de-identifies patient health data, meaning it removes personal information that could identify an individual. This software also links patient records from different sources, ensuring that the data can be used cohesively without compromising privacy.

Datavant serves a variety of clients, including hospitals, research institutions, pharmaceutical companies, and public health organizations. These clients use Datavant's technology to access and share health data securely, which is essential for research, treatment, and public health initiatives. For example, during the COVID-19 pandemic, Datavant's technology has been instrumental in linking disparate datasets to understand the virus's impact on different populations.

The company operates in the health data infrastructure market, a niche but growing segment driven by the increasing need for data interoperability and privacy. Datavant's business model is based on a software-as-a-service (SaaS) approach. Clients pay for access to the software, which can be customized to meet their specific needs. This model provides a steady stream of recurring revenue, as clients typically subscribe to the service on an annual basis.

Datavant makes money by charging subscription fees for its software. These fees can vary depending on the size of the client and the complexity of their data needs. Additionally, the company may offer consulting services to help clients implement and optimize their use of the software, providing another revenue stream.

In summary, Datavant is a key player in the health data technology space, offering essential tools for secure data sharing and privacy preservation. Its client base includes major healthcare providers and researchers, and it operates on a subscription-based business model.